Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Discovery of biomarkers predictive of GSI response in triple-negative breast cancer and adenoid cystic carcinoma.

Autor: Stoeck A; Merck Research Laboratory, Boston, Massachusetts. ssathy@jouncetx.com jaster@rics.bwh.harvard.edu Alexander.Stoeck@merck.com., Lejnine S; Merck Research Laboratory, Boston, Massachusetts., Truong A; Merck Research Laboratory, Boston, Massachusetts., Pan L; Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts., Wang H; Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts., Zang C; Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, Massachusetts., Yuan J; Merck Research Laboratory, Boston, Massachusetts., Ware C; Merck Research Laboratory, Boston, Massachusetts., MacLean J; Merck Research Laboratory, Boston, Massachusetts., Garrett-Engele PW; Merck Research Laboratory, Boston, Massachusetts., Kluk M; Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts., Laskey J; Merck Research Laboratory, Boston, Massachusetts., Haines BB; Merck Research Laboratory, Boston, Massachusetts., Moskaluk C; Department of Medicine and Digestive Health Research Center, University of Virginia, Charlottesville, Virginia., Zawel L; Merck Research Laboratory, Boston, Massachusetts., Fawell S; Merck Research Laboratory, Boston, Massachusetts., Gilliland G; Merck Research Laboratory, Boston, Massachusetts., Zhang T; Merck Research Laboratory, Boston, Massachusetts., Kremer BE; Department of Pathology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania., Knoechel B; Department of Pathology and Center for Cancer Research, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts., Bernstein BE; Department of Pathology and Center for Cancer Research, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts., Pear WS; Department of Pathology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania., Liu XS; Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, Massachusetts., Aster JC; Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts., Sathyanarayanan S; Merck Research Laboratory, Boston, Massachusetts. ssathy@jouncetx.com jaster@rics.bwh.harvard.edu Alexander.Stoeck@merck.com.

Publikováno v: Cancer discovery [Cancer Discov] 2014 Oct; Vol. 4 (10), pp. 1154-67. Date of Electronic Publication: 2014 Aug 07.

Plasma MicroRNAs as sensitive and specific biomarkers of tissue injury.

Autor: Laterza OF; Merck Research Laboratories, Clinical Development Laboratory, Rahway, NJ, USA., Lim L, Garrett-Engele PW, Vlasakova K, Muniappa N, Tanaka WK, Johnson JM, Sina JF, Fare TL, Sistare FD, Glaab WE

Publikováno v: Clinical chemistry [Clin Chem] 2009 Nov; Vol. 55 (11), pp. 1977-83. Date of Electronic Publication: 2009 Sep 10.

Dissection of the signal for DNA methylation in the zeta-eta region of Neurospora.

Autor: Selker EU; Institute of Molecular Biology, University of Oregon, Eugene 97403-1299., Richardson GA, Garrett-Engele PW, Singer MJ, Miao V

Publikováno v: Cold Spring Harbor symposia on quantitative biology [Cold Spring Harb Symp Quant Biol] 1993; Vol. 58, pp. 323-9.